Sort
82,697 grants matching “vaccine development”
The effect of HIV exposure and infection on immunity to TB in children
$793,352Grace C John-Stewart · University Of Washington · R01 · FY2020 · AI
Novel Mucosal Adjuvant for an HIV DNA Vaccine
$793,348Kenneth C Bagley · Profectus Biosciences, Inc. · R44 · FY2017 · AI
IMMUNOBIOLOGY OF VARICELLA AND ZOSTER IN A PRIMATE MODEL
$793,333Ravi Mahalingam · University Of Colorado Denver · P01 · FY2016 · AG
Supramolecular pediatric HIV vaccine design
$793,206Genevieve Giny Fouda Amou Ou · Duke University · R01 · FY2019 · AI
Task V15: Development of Assays and Reagents for mpox Vaccines
$793,164Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2025 · AI
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
$793,149Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
The interplay of maternal antibody and newborn vaccine responses
$793,102Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2025 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients
$793,078Jennifer K. Lodge · Duke University · R01 · FY2024 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients
$793,078Jennifer K. Lodge · Duke University · R01 · FY2023 · AI
Mechanisms Of Protection of Universal Therapeutic Antibodies To Influenza A
$793,063Silke Paust · Baylor College Of Medicine · R01 · FY2017 · AI
Development of an oral liver-targeted prime-and-trap malaria vaccine
$793,041Sean C Murphy · University Of Washington · U01 · FY2025 · AI
Phase I trial of two candidate live oral salmonella enterica serovar paratyphi A
$793,003Myron Max Levine · University Of Maryland Baltimore · U54 · FY2010 · AI
Optimizing protective vaccine targets in the V1/V2 domain of HIV-1 gp120
$792,991Abraham Pinter · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Project 2: Structure-based antigen and nanoparticle vaccine design
$792,967Neil King · University Of Washington · P01 · FY2022 · AI
Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children
$792,925Lisa M Bebell · Massachusetts General Hospital · R01 · FY2024 · HD
Microbiome-driven immune changes and growth stunting in HIV-exposed uninfected children
$792,899Lisa M Bebell · Massachusetts General Hospital · R01 · FY2025 · HD
Natural killer cell regulation of the germinal center HIV neutralizing antibody response
$792,838Todd Christopher Bradley · Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2023 · AI
Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120
$792,805Asim K Debnath · New York Blood Center · R01 · FY2021 · AI
Design of inhibitors targeted to the CD4 binding site on HIV-1 gp120
$792,805Asim K Debnath · New York Blood Center · R01 · FY2020 · AI
Structure-function studies of the membrane-interacting domains of HIV-1 Env spike
$792,780Bing Chen · Boston Children'S Hospital · R01 · FY2020 · AI
Dissecting virus neutralizing determinants to guide HCV vaccine development
$792,744Mansun Law · Scripps Research Institute, The · R56 · FY2013 · AI
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
$792,724Albert C Shaw · Yale University · R01 · FY2020 · AG
Research Capacity Core
$792,687Micheler Ricardo Richardson · North Carolina Central University · U54 · FY2024 · MD
Adjuvants for Skin Immunization: Discovery and Mechanisms
$792,636Ioanna Skountzou · Emory University · R01 · FY2015 · AI
Preventing TB with intravenous BCG in SIV-infected macaques
$792,599Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI